Global E-Pharmacy Market Size & Share to 2027 – Featuring Pharmacy2U, Gordons Direct and MedPlus Health Services Among Others –

DUBLIN–(BUSINESS WIRE)–The “Global E-Pharmacy Market Size & Share to 2027” report has been added to’s offering. E-pharmacy is referred as electronic pharmacy or internet pharmacy. It is an online retail platform which acts as bridge between consumers and vendors to enable the sales of medicines. It provides round-the-clock delivery of drugs access to comprehensive … [Read more…]

Worldwide Bone Growth Stimulators Industry to 2026 – Technology Advancements in Implants Drive Surgery Volumes, Supporting Demand for Bone Stimulators –

DUBLIN–(BUSINESS WIRE)–The “Bone Growth Stimulators – Global Market Trajectory & Analytics” report has been added to’s offering. The global market for Bone Growth Stimulators estimated at US$999.4 Million in the year 2020, is projected to reach a revised size of US$1.27 Billion by 2026, growing at a CAGR of 4.2% over the analysis period. … [Read more…]

Global G-Protein Coupled Receptors (GPCRs) Market Report to 2027 – Developments in Structural Biology and Receptor Pharmacology Offer Novel Opportunities –

DUBLIN–(BUSINESS WIRE)–The “G-Protein Coupled Receptors (GPCRs) – Global Market Trajectory & Analytics” report has been added to’s offering. The global market for G-Protein Coupled Receptors (GPCRs) estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$3.7 Billion by 2026, growing at a CAGR of 5.7% over the … [Read more…]

World Anti-Doping in Sport Thematic Research Report 2022 with an Overview of the Sport’s History with the Issue –

DUBLIN–(BUSINESS WIRE)–The “Anti-Doping in Sport – Thematic Research” report has been added to’s offering. An analysis of the problems facing sport with regards to anti-doping and cheating, and an overview of sport’s history with the issue With increased commercialization and an ever-increasing amount of money involved, the stakes in sport have never been higher. … [Read more…]

The Worldwide Femtech Industry is Expected to Reach $58.8 Billion by 2027 –

DUBLINDUBLIN–(BUSINESS WIRE)–The “Femtech Market Research Report by Type (Products, Services, and Software), Application, End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to’s offering. The Global Femtech Market size was estimated at USD 24.99 billion in 2021 and expected … [Read more…]

Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA® ▼(burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)

CRYSVITA could offer access to the first biologic treatment for EU patients with TIO who cannot undergo surgical removal of tumours TOKYO–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended that CRYSVITA® (burosumab) be approved … [Read more…]

Innovaccer Joins the CARIN Alliance to Advance Access and Interoperability in the Healthcare Ecosystem

Innovaccer will participate as a member of the multisector alliance to advance healthcare data sharing, enabling consumers, patients, and caregivers easier access to health information SAN FRANCISCO–(BUSINESS WIRE)–Today, Innovaccer Inc., the Health Cloud company, announced that it has joined the CARIN Alliance (CARIN), a multisector collaborative working to rapidly advance the consumer-directed exchange of health … [Read more…]

Dr. Reddy’s Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Acquisition–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has acquired a portfolio of branded and generic injectable products from Deer Park, Illinois based-Eton Pharmaceuticals, Inc. (NASDAQ: ETON). The portfolio includes the … [Read more…]

Propanc Biopharma Announces No Immediate Plans for Reverse Stock Split

Company Filed a Definitive Information Statement Under Section 14C of the Exchange Act MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company filed a Definitive Information Statement under Section 14C of the Exchange … [Read more…]